RiverPark Advisors’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-600,780
Closed -$6.25M 213
2021
Q3
$6.25M Hold
600,780
0.76% 45
2021
Q2
$6.31M Buy
+600,780
New +$5.93M 0.8% 44
2021
Q1
Sell
-529,071
Closed -$5.86M 135
2020
Q4
$5.86M Buy
+529,071
New +$5.4M 1.03% 35

Other funds holding SRTA

RiverPark Advisors's SRTA Position: Q4 2021 in Review

RiverPark Advisors sold out of Strata Critical Medical Inc (SRTA) in Q4 2021, closing a stake of 600,780 shares — an estimated $6.25M sold.

RiverPark Advisors first reported a position in SRTA in Q4 2020 and held it in 3 quarters. The position peaked at $6.31M in Q2 2021. 79 funds tracked by Wall St. Rank hold SRTA as of Q4 2021.

  • RiverPark Advisors reported no remaining Strata Critical Medical Inc position as of Q4 2021 after selling out during the quarter.
  • RiverPark Advisors sold 600,780 Strata Critical Medical Inc shares in Q4 2021, an estimated $6.25M.
  • RiverPark Advisors first reported a position in Strata Critical Medical Inc in Q4 2020 and held it in 3 quarters.
  • RiverPark Advisors's Strata Critical Medical Inc position peaked at $6.31M in Q2 2021.
  • 79 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q4 2021.

Based on RiverPark Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.